Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA499472
Max Phase: Preclinical
Molecular Formula: C43H57N5O6S
Molecular Weight: 772.02
Molecule Type: Small molecule
Associated Items:
ID: ALA499472
Max Phase: Preclinical
Molecular Formula: C43H57N5O6S
Molecular Weight: 772.02
Molecule Type: Small molecule
Associated Items:
Synonyms (1): KNI-10652
Synonyms from Alternative Forms(1):
Canonical SMILES: CC(C)CNC(=O)[C@H]1N(C(=O)[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCc2ccccc2)c2ccccc2)C(C)(C)C)CSC1(C)C
Standard InChI: InChI=1S/C43H57N5O6S/c1-28(2)26-44-40(53)37-43(6,7)55-27-48(37)41(54)35(50)32(25-30-19-13-9-14-20-30)45-39(52)36(42(3,4)5)47-38(51)34(31-21-15-10-16-22-31)46-33(49)24-23-29-17-11-8-12-18-29/h8-22,28,32,34-37,50H,23-27H2,1-7H3,(H,44,53)(H,45,52)(H,46,49)(H,47,51)/t32-,34-,35-,36+,37+/m0/s1
Standard InChI Key: VUHLOESWQWNVHT-CTFQGTJTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 772.02 | Molecular Weight (Monoisotopic): 771.4030 | AlogP: 4.55 | #Rotatable Bonds: 16 |
Polar Surface Area: 156.94 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.81 | CX Basic pKa: | CX LogP: 5.01 | CX LogD: 5.01 |
Aromatic Rings: 3 | Heavy Atoms: 55 | QED Weighted: 0.14 | Np Likeness Score: 0.24 |
1. Zhang M, Nguyen JT, Kumada HO, Kimura T, Cheng M, Hayashi Y, Kiso Y.. (2008) Synthesis and activity of tetrapeptidic HTLV-I protease inhibitors possessing different P3-cap moieties., 16 (10): [PMID:18400502] [10.1016/j.bmc.2008.03.055] |
Source(1):